Literature DB >> 8762193

Expression of apolipoprotein E inhibits aggregation of the C-terminal fragments of beta-amyloid precursor protein.

T Ohman1, N Dang, R C LeBoeuf, C E Furlong, K Fukuchi.   

Abstract

An important role of apolipoprotein E in the amyloidogenesis of Alzheimer's disease is suggested by an accumulation of apolipoprotein E in beta-amyloid plaques and a genetic association between Alzheimer's disease and one of the allelic variants (APOE4) of apolipoprotein E. Overexpression of a C-terminal region of beta-amyloid precursor protein brings about aggregation of the C-terminal fragments in COS cells. This COS cell culture system was used to study effects of apolipoprotein E on aggregation of the C-terminal fragments. When both apolipoprotein E and the C-terminal fragments were overexpressed in COS cells, Western blot analyses revealed significant inhibition of aggregation of the C-terminal fragments. No significant differences between apolipoprotein E3 and E4 in the inhibitory activities were found by this method. Apolipoprotein E may inhibit formation of amyloid fibrils.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8762193     DOI: 10.1016/0304-3940(96)12663-x

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  2 in total

1.  Accumulation of amyloid-beta protein in exocrine glands of transgenic mice overexpressing a carboxyl terminal portion of amyloid protein precursor.

Authors:  K Fukuchi; L Li; M Hart; J R Lindsey
Journal:  Int J Exp Pathol       Date:  2000-08       Impact factor: 1.925

2.  Candidate SNP Markers of Familial and Sporadic Alzheimer's Diseases Are Predicted by a Significant Change in the Affinity of TATA-Binding Protein for Human Gene Promoters.

Authors:  Petr Ponomarenko; Irina Chadaeva; Dmitry A Rasskazov; Ekaterina Sharypova; Elena V Kashina; Irina Drachkova; Dmitry Zhechev; Mikhail P Ponomarenko; Ludmila K Savinkova; Nikolay Kolchanov
Journal:  Front Aging Neurosci       Date:  2017-07-20       Impact factor: 5.750

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.